HCID 90026195, compound → HCID 72705091, compound

HRID 1054988Notes

Reaction equation

HRID 1054988 reaction equation
[CH3:1][C:2]1[N:7]2[N:8]=[C:9](/[CH:11]=[CH:12]/[C:13]3[N:17]([CH3:18])[N:16]=[C:15]([N:19]4[CH2:24][CH2:23][CH2:22][CH2:21][CH2:20]4)[N:14]=3)[N:10]=[C:6]2[C:5]([CH3:25])=[N:4][CH:3]=1>[Pd].CO>[CH3:1][C:2]1[N:7]2[N:8]=[C:9]([CH2:11][CH2:12][C:13]3[N:17]([CH3:18])[N:16]=[C:15]([N:19]4[CH2:24][CH2:23][CH2:22][CH2:21][CH2:20]4)[N:14]=3)[N:10]=[C:6]2[C:5]([CH3:25])=[N:4][CH:3]=1

Participants

4

Reactant 1

HCID 90026195HCID 90026195, compound

Product 1

HCID 72705091HCID 72705091, compoundYield 57.4%

Reagents, catalysts & solvents 2

HCID 23938PalladiumCatalystHCID 887MethanolSolvent

Conditions

Temperature
25 °C

Procedure

A mixture of (E)-5,8-dimethyl-2-(2-(1-methyl-3-(piperidin-1-yl)-1H-1,2,4-triazol-5-yl)vinyl)-[1,2,4]triazolo[1,5-a]pyrazine (52 mg, 154 μmol, Eq: 1.00) and palladium on carbon 10% (16.4 mg, 15.4 μmol, Eq: 0.1) in methanol (20 ml) was stirred for 24 hours at 25° C. under a hydrogen atmosphere. The catalyst was filtered off, the filtrate was evaporated affording 5,8-dimethyl-2-[2-(2-methyl-5-piperidin-1-yl-2H-[1,2,4]triazol-3-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine (30 mg, 57.4%) as a yellow oil. MS: m/z=341.5 (M+H+)

Workup

  1. filtrationThe catalyst was filtered off
  2. customthe filtrate was evaporated

Sources & evidence

ORD record
ord-88913155c5e94f94a1574d24b5f1d635
Source dataset
uspto-grants-2016_07
Patent number
US09394311B2

Reaction notes

Loading…